Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Temporal dynamics and prognostic value of serum calcitonin during tirzepatide therapy in adults with obesity.

Created on 11 Nov 2026

Authors

Nikolaos Angelopoulos, George Simeakis, Ioannis Androulakis, Andreas Rizoulis, Anastasios Boniakos, Paraskevi Mentzelopoulou, Areti Korakovouni, Dimitra Zianni, Valentina Petkova, Sarantis Livadas, Rodis Paparodis

Published in

Obesity research & clinical practice. Nov 10, 2026. Epub Nov 10, 2026.

Abstract

To characterize serum calcitonin dynamics during six months of tirzepatide therapy for obesity and explore whether early changes are associated with subsequent biochemical behavior.
This prospective observational study enrolled 77 adults with obesity initiating tirzepatide. One participant diagnosed with medullary thyroid carcinoma at baseline was excluded, leaving 76 participants for longitudinal analysis. Serum calcitonin was assessed at baseline, 3 months, and 6 months. Longitudinal changes were evaluated using non-parametric tests and mixed-effects models; prognostic analyses were exploratory.
Median calcitonin increased modestly from 2.05 pg/mL at baseline to 2.12 pg/mL at 3 months and 2.25 pg/mL at 6 months, with a significant overall time effect (p < 0.001) but no further significant change between 3 and 6 months (p = 0.43). Two participants with baseline calcitonin < 12 pg/mL developed new-onset elevations ≥ 12 pg/mL during early follow-up; no additional cases occurred at 6 months. Early calcitonin change was strongly associated with six-month change (Spearman ρ=0.73, p < 0.001), although prognostic analyses were limited by only two threshold events. Median weight loss was 8.3% and 15.0% at 3 and 6 months, respectively.
Tirzepatide was associated with a small early increase in serum calcitonin followed by stabilization through six months. Early calcitonin changes were associated with subsequent biochemical behavior, but the limited follow-up and small number of threshold events preclude conclusions regarding prognostic cutoffs or monitoring strategies.

PMID:
43009382
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement